Open Enrollment starts November 1, and many people are confused about the rules and options. That’s understandable. The noise created by the failed attempts to dismantle the Affordable Care Act makes it hard to know what’s accurate and who to trust.
CancerCare has partnered with Barbells for Boobs, a nonprofit with a mission to help mobilize and empower propel to take action in breast cancer, to pioneer a breast health support line in New York City. The support line will direct individuals to services and screenings regardless of age, gender, income and insurance status. Those seeking assistance can call the NYC Support Line at 855-BFB-2DAY.
February 4th is World Cancer Day. 18 years ago, World Cancer Day was created to raise political awareness of cancer and to work towards decreasing prevalence of cancer by the year 2020. This year’s theme is “We Can. I Can.” and inspires individuals and groups to make small changes in their lives to make a larger collective impact. Here are a few ways to get involved this year:
CancerCare staff remembers Dr. Jimmie Holland, who founded the field of psycho-oncology.
For nearly a decade, the most distinguished minds in cancer care have advocated for shared decision-making — patients partnering with their clinicians to make informed decisions that are consistent with their needs, values, and preferences. Although widely perceived as the gold standard for decision-making, in cancer care it seems to be the exception rather than the rule.
Did you know that right now, people who are not satisfied with their Medicare Advantage Plan can switch to Original Medicare? The Medicare Advantage Disenrollment Period runs from January 1 to February 14 each year. Read on to learn more!
This information is republished with permission from the Medicare Rights Center.
Four members of CancerCare were invited to participate in a morning of roundtable discussions at the White House on January 11.
This past October, CancerCare held a roundtable discussion titled “Improving the Quality of Life for Lung Cancer Patients” at its national headquarters in New York City. Celebrated lung cancer advocates and key opinion leaders in lung cancer treatment held a dialogue and gave presentations reviewing the significance of patient-reported outcomes related to patients with lung cancer.
A recent survey conducted by CancerCare of more than 1,300 breast, colon, lung and prostate cancer patients diagnosed within the past five years found that the vast majority had not heard the term “clinical pathway”. Even after it was defined, fewer than half claimed to be familiar with the term.